Jaro Institute of Technology Management and Research Limited announced key corporate decisions following its board meeting held on January 21, 2026. The meeting, which commenced at 5:30 PM and concluded at 6:00 PM, addressed significant matters related to employee benefits, board composition, and equity allotments.

New ESOP Scheme 2026 Approved

The board approved the Jaro Education Employees Stock Option Plan 2026, establishing a comprehensive framework for employee stock options. The scheme details are outlined below:

The exercise price will be determined by the Nomination and Remuneration Committee at the time of grant, linked to market price in accordance with applicable law. The committee retains authority to provide suitable discounts, though the exercise price cannot fall below the share's par value of ₹10.00. The scheme requires shareholder approval through postal ballot before implementation.

Independent Director Reappointment

The board recommended reappointment of Mr. Ishan Baveja (DIN: 07251062) as Independent Director for a second term of five years, effective February 4, 2026, subject to shareholder approval.

Mr. Baveja holds a bachelor's degree in commerce from Hemwati Nandan Bahuguna Garhwal University and is a fellow member of the Institute of Chartered Accountants of India. He has been practicing as a chartered accountant since 2013 and serves as partner with M/s Baveja Gupta & Co. since 2015, bringing over 12 years of accounting sector experience. He currently serves as board member of Maasheetla Ventures Limited and Lifestyle & Media Holdings Limited.

Equity Share Allotment Under Existing ESOP

The board approved and allotted 20,050 fully paid-up equity shares of ₹10.00 each upon exercise of options granted under the Jaro Education ESOP Scheme 2022. The allotment includes bonus shares issued in accordance with the 1:3 bonus ratio approved by shareholders on May 24, 2024.

The allotment encompasses shares from ESOP Grant 1 dated May 2, 2022, and ESOP Grant 2 dated July 27, 2024. Following this allotment, the company's total issued shares increased to 2,21,76,339, bringing the total issued share capital to ₹22,17,63,390.

Corporate Compliance and Next Steps

All decisions were made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant SEBI guidelines. The company will seek shareholder approval for both the new ESOP Scheme 2026 and Mr. Baveja's reappointment through postal ballot processes. The newly allotted shares under the existing ESOP scheme are issued in dematerialized form and are identical to existing shares in all respects.

Jaro Institute of Technology Management and Research Limited has declared an interim dividend of 20%, equivalent to Rs. 2.00 per equity share of face value Rs. 10.00 each, for the financial year 2025-26. The Board of Directors approved this decision during their meeting held on January 2, 2026, following their earlier announcement on December 30, 2025.

Board Meeting Outcome

The Board of Directors convened as scheduled and successfully concluded the meeting with the interim dividend declaration. The meeting commenced at 12:00 Noon and concluded at 12:30 PM, demonstrating efficient decision-making by the board.

Payment and Record Date Details

The company has established clear timelines for dividend payment and shareholder eligibility. The interim dividend will be paid to eligible shareholders on or before January 31, 2026. In accordance with Regulation 42 of SEBI (LODR), the Board has fixed Friday, January 16, 2026, as the record date for determining shareholder eligibility.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The communication was filed with both BSE Limited and National Stock Exchange of India Limited, where the company is listed with scrip code 544534 and symbol JARO respectively.

Shareholder Eligibility

Shareholders whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners as of the record date will be eligible for the interim dividend payment. The regulatory filing was signed by Sanjay Namdeo Salunkhe, Managing Director (DIN: 01900632), and submitted from Mumbai to both major stock exchanges where the company maintains its listing status.